本文已被:浏览 22次 下载 50次
投稿时间:2025-09-29 网络发布日期:2026-04-02
投稿时间:2025-09-29 网络发布日期:2026-04-02
中文摘要: 目的探究唾液酸结合免疫球蛋白样凝集素15(Siglec-15)在喉鳞状细胞癌(LSCC)中的表达模式,及与临床特征的相关性。方法访问UCSC Xena数据库,获取癌症基因组图谱(TCGA)数据库中LCSS基因表达谱和临床数据。同时对南通大学附属医院2000—2009 年收治的49例LSCC患者的肿瘤组织及癌旁组织进行免疫组化(IHC)检测,对Siglec-15表达及重要临床指标进行相关性分析。结果生物信息学分析结果显示,相比于癌旁组织,Siglec-15在LSCC肿瘤组织中表达显著上调。TGCA的临床资料显示,Siglec-15高表达患者的总生存时间显著低于低表达患者[368(230,589)d vs 495(286,1 472)d,P=0.034]。对49例LSCC患者所行的Kaplan-Meier生存分析结果显示Siglec-15高表达(P=0.021)、女性(P=0.012)以及淋巴结转移阳性(P=0.002)患者的预后较差。结论Siglec-15在LSCC中异常高表达,且与淋巴结转移阳性和较差的生存结局相关。
Abstract:Objective To investigate the expression pattern of sialic acid-binding immunoglobulin-like lectin 15 (Siglec- 15) in laryngeal squamous cell carcinoma (LSCC) and its correlation with clinical characteristics. Methods The UCSCXena data base was accessed to obtain the gene expression profiles and clinical data of LSCC from The Cancer Genome Atlas (TCGA) database. Additionally, tumor tissues and adjacent tissues from 49 LSCC patients admitted to the Affiliated Hospital of Nantong University between 2000 and 2009 were collected for immunohistochemistry (IHC) detection. Correlation analysis was performed between Siglec-15 expression and key clinical indicators. Results Bioinformatics analysis revealed that Siglec-15 expression was significantly upregulated in LSCC compared with adjacent tissues. Clinical data from TCGA showed that the overall survival of patients with high Siglec-15 expression was significantly shorter than that of patients with low expression [368 (230, 589) days vs 495 (286, 1 472) days, P=0.034]. Kaplan- Meier survival analysis performed on 49 patients with LSCC indicated that high Siglec- 15 expression (P=0.021), female gender (P=0.012), and positive lymph node metastasis (P=0.002) were associated with poorer prognosis. Conclusion Siglec-15 is abnormally highly expressed in LSCC and is correlated with positive lymph node metastasis and poor survival outcomes.
文章编号: 中图分类号:R739.65 文献标志码:A
基金项目:国家自然科学基金面上项目(82473332);江苏省自然科学基金面上项目(BK20241750)
附件
引用文本:
杜奇隆,杨俊荣,许里,等.Siglec-15在老年喉鳞状细胞癌患者中的表达及其临床意义[J].中国临床研究,2026,39(3):424-428.
杜奇隆,杨俊荣,许里,等.Siglec-15在老年喉鳞状细胞癌患者中的表达及其临床意义[J].中国临床研究,2026,39(3):424-428.
